Regenerative technologies to bed side: Evolving the regulatory framework

There are high expectations for the clinical application of regenerative medicine technologies to treat musculoskeletal disorders. However, there are still big hurdles in bringing cell-based products to the market, mainly due to strict regulatory frameworks to approve these. Recently, the Japanese P...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakai, Daisuke, Schol, Jordy, Foldager, Casper B., Sato, Masato, Watanabe, Masahiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chinese Speaking Orthopaedic Society 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5822969/
https://www.ncbi.nlm.nih.gov/pubmed/29662794
http://dx.doi.org/10.1016/j.jot.2017.02.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5822969/
https://www.ncbi.nlm.nih.gov/pubmed/29662794
http://dx.doi.org/10.1016/j.jot.2017.02.001

Ejemplares similares